MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202511122290 A) filed by K. R. Mangalam University, Gurugram, Haryana, on Dec. 5, 2025, for 'biodegradable microneedle array patch for targeted intra-articular drug delivery in arthritis treatment.'
Inventor(s) include Dr. Hema Chaudhary; Dr Ruby Jindal; Mr. Mohit Agrawal; and Dr. Archana.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "A novel invention consists of a biodegradable microneedle patch used for the localized and sustained delivery of anti-inflammatory drugs to help with the management of arthritis. The microneedles are made from bio polymers with slowly degrading properties, and are further customized with polymers that can target drug accumulation in the joint tissues. The microneedles can harmlessly puncture the skin and release the drug-loaded biodegradable tips located in the dermis for a controlled drug release for a long duration. Because of the microneedles, drug delivery can bypass the parenteral route entirely, thus minimizing common adverse effects that are often associated with chemotherapy. The patch is a friendly and clinically effective means for arthritic patients to minimize the long-term effects of inflammatory joint diseases."
Disclaimer: Curated by HT Syndication.
